Table 4.
Colesevelam (n=17) | Placebo (n=14) | Difference | |||||
---|---|---|---|---|---|---|---|
Baseline | Posttreatment | P-Value | Baseline | Posttreatment | P-Value | (P-Value) | |
Steatosis | |||||||
Mean ± SE | 2.00 (0.7) | 1.53 (0.8) | 0.021 | 1.86 (0.8) | 1.50 (0.8) | 0.096 | 0.598 |
Median ± IQR | 2.0 (1.5-2.5) | 1.0 (1.0-2.0) | 2.0 (1.0-2.25) | 1.5 (1.0-2.0) | |||
N grade 0/1/2/3 | 0/4/9/4 | 0/11/3/3 | 0/5/6/3 | 1/6/6/1 | |||
Lobular inflammation | |||||||
Mean ± SE | 1.82 (0.7) | 1.59 (0.7) | 0.248 | 1.43 (0.7) | 1.71 (0.7) | 0.102 | 0.069 |
Median ± IQR | 2.0 (1.0-2.0) | 1.0 (1.0-2.0) | 1.0 (1.0-2.0) | 2.0 (1.0-2.0) | |||
N grade 0/1/2/3 | 0/6/8/3 | 0/9/6/2 | 0/9/4/1 | 0/6/6/2 | |||
Ballooning | |||||||
Mean ± SE | 1.12 (0.8) | 1.06 (0.7) | 0.782 | 1.07 (0.7) | 1.14 (0.7) | 0.655 | 0.488 |
Median ± IQR | 1.0 (0.5-2.0) | 1.0 (0.5-2.0) | 1.0 (0.75-2.0) | 1.0 (1.0-2.0) | |||
N grade 0/1/2 | 4/7/6 | 4/8/5 | 3/7/4 | 2/8/4 | |||
Fibrosis | |||||||
Mean ± SE | 1.12 (1.5) | 1.06 (1.3) | 0.660 | 1.36 (1.6) | 1.50 (1.4) | 0.480 | 0.229 |
Median ± IQR | 0 (0.0-3.0) | 1.0 (0.0-2.0) | 1.0 (0.0-3.0) | 1.0 (0.0-2.25) | |||
Stage 0/1/2/3/4 | 9/3/0/4/1 | 8/4/2/2/1 | 6/3/1/2/2 | 4/4/3/1/2 | |||
NAS | |||||||
Mean ± SE | 4.89 (1.3) | 4.18 (1.8) | 0.151 | 4.36 (1.3) | 4.36 (1.8) | 0.927 | 0.136 |
Median ± IQR | 5.0 (4.0-6.0) | 3.0 (3.0-6.0) | 4.0 (3.75-5.0) | 4.0 (3.0-5.25) |
Data are expressed as means with standard error in parentheses or as median with interquartile range in parentheses.
SE, standard error; IQR, interquartile range.
Nonparametric tests (Wilcoxon-rank sum test) for related samples and independent samples were performed on all variables for histologic comparisons within groups and between groups respectively. Mean differences reflect comparison between baseline averages minus posttreatment values.